Cargando…
HIF2a inhibitors for the treatment of VHL disease
Autores principales: | Metelo, Ana Martins, Noonan, Haley, Iliopoulos, Othon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695098/ https://www.ncbi.nlm.nih.gov/pubmed/26325097 |
Ejemplares similares
-
Loss of vhl in the zebrafish pronephros recapitulates early stages of human clear cell renal cell carcinoma
por: Noonan, Haley R., et al.
Publicado: (2016) -
Understanding the Impact of Belzutifan on Treatment Strategies for Patients with VHL
por: Arevalo, Aileen, et al.
Publicado: (2022) -
VHL-P138R and VHL-L163R Novel Variants: Mechanisms of VHL Pathogenicity Involving HIF-Dependent and HIF-Independent Actions
por: Mathó, Cecilia, et al.
Publicado: (2022) -
Playing Tag with HIF: The VHL Story
por: Leung, Sherri K., et al.
Publicado: (2002) -
The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma
por: Peng, Song, et al.
Publicado: (2020)